english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

DSM: still riddled with conflicts of interests

Finerenone (Kerendia°) in chronic kidney disease with albuminuria associated with type 2 diabetes

Solifenacin + tamsulosin (Vecalmys°/Vesomni°) in benign prostatic hyperplasia: not acceptable

Environmental impact of drugs: taking drug utilisation data into account

European "pharmaceutical package": letter on clinical data exclusivity

Short-term interruption of treatment with a xaban or dabigatran: sometimes fatal thrombosis

Phasing out patient leaflets in paper form: eco-responsible or irresponsible?

Selinexor (Nexpovio°) in relapsed or refractory multiple myeloma: not acceptable

Bupropion + naltrexone (Mysimba°) for weight loss: set to be withdrawn from the market in the European Union?

In-utero exposure to corticosteroids: increased risk of serious infections during the first year of life

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90